You have 9 free searches left this month | for more free features.

Secondary Malignant Cerebellar Tumor

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Genetics of Appendix Cancer Study

Recruiting
  • Appendix Cancer
  • +14 more
  • Genetic profiling
  • Retrospective tissue procurement
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Feb 8, 2023

Gastric Adenocarcinoma, Malignant Melanoma Trial in Seoul (AZD6738, Durvalumab)

Active, not recruiting
  • Gastric Adenocarcinoma
  • Malignant Melanoma
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jun 13, 2022

Secondary Malignant Tumor of Brain and Cerebral Meninges Trial in Cleveland (18F-fluciclovine, PET/CT of the brain)

Completed
  • Secondary Malignant Neoplasm of Brain and Cerebral Meninges
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
May 3, 2021

Cerebellar Stroke Trial (suboccipital decompressive craniectomy)

Completed
  • Cerebellar Stroke
  • suboccipital decompressive craniectomy
  • (no location specified)
Jan 1, 2023

Malignant Tumor Trial (Experimental: DaRT seeds)

Not yet recruiting
  • Malignant Tumor
  • Experimental: DaRT seeds
  • (no location specified)
Mar 27, 2023

Circulating and Tumor-infiltrating Immune Cells in Malignant

Recruiting
  • Brain Tumor, Primary
  • Brain Tumor - Metastatic
  • Circulating leukocytes immunophenotype
  • Tumor sampling
  • Milan, Italy
    IRCCS San Raffaele Scientific Institute
Apr 14, 2023

Cancer Ratio,Pleural Fluid Adenosine Deaminase,Lactate

Not yet recruiting
  • Pleural Effusion, Malignant
  • pleural markers
  • (no location specified)
Jan 20, 2023

Perioperative Evaluation of Cerebellar Tumors

Recruiting
  • Cerebellar Tumors
  • Brain Tumor
  • Impact of Cerebellar Functional Topography on Cognition and Motor Ataxia
  • Durham, North Carolina
    Duke University Medical Center
Jan 27, 2022

Brain Tumor Recurrent Trial in Houston (Methotrexate, Etoposide, Ommaya Reservoir)

Recruiting
  • Brain Tumor Recurrent
  • Houston, Texas
    UTHealth & Children's Memorial Hermann Hospital
Aug 17, 2022

Unresectable Stage IIIB-IV Malignant Melanoma Trial in Japan (Talimogene laherparepvec)

Completed
  • Unresectable Stage IIIB-IV Malignant Melanoma
  • Talimogene laherparepvec
  • Nagoya-shi, Aichi, Japan
  • +8 more
Jan 13, 2023

Malignant Brain Tumor, Malignant Glioma, Embryonal Tumor Trial in Paris, Villejuif (SonoCloud® (9 transducers))

Not yet recruiting
  • Malignant Brain Tumor
  • +2 more
  • SonoCloud® (9 transducers)
  • Paris, France
  • +2 more
Sep 26, 2022

Intracranial Tumor Trial in Portland (Magnetic Resonance Imaging, Oxygen Therapy)

Recruiting
  • Intracranial Neoplasm
  • Magnetic Resonance Imaging
  • Oxygen Therapy
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jun 6, 2023

Localized or Diffuse Pruritus inPopulation With One or Several,

Completed
  • Pruritus
  • Brain Tumor
    • Brest, France
      Service de dermatologie, CHRU BREST
    Jan 12, 2022

    Brain Stem Glioma, Cerebral Astrocytoma, Childhood Cerebellar Anaplastic Astrocytoma Trial in Canada, United States

    Active, not recruiting
    • Brain Stem Glioma
    • +4 more
    • Bevacizumab
    • +2 more
    • Birmingham, Alabama
    • +136 more
    Oct 15, 2022

    Diffuse Midline Glioma (DMG), Glioblastoma, Recurrent Ependymoma Trial in San Francisco, Ann Arbor, Zürich (ONC206, Standard of

    Recruiting
    • Diffuse Midline Glioma (DMG)
    • +7 more
    • ONC206
    • Standard of Care Radiation Therapy
    • San Francisco, California
    • +2 more
    Sep 13, 2022

    Cervical Cancer, Ovarian Cancer, Malignant Trophoblastic Tumor Trial (Toripalimab + ScTIL)

    Not yet recruiting
    • Cervical Cancer
    • +2 more
    • Toripalimab + ScTIL
    • (no location specified)
    Apr 17, 2022

    Advanced Solid Tumor, Stereotactic Body Radiotherapy, Immune Checkpoint Inhibitor Trial in Peking (Cadonilimab, Stereotactic

    Not yet recruiting
    • Advanced Solid Tumor
    • +4 more
    • Peking, Beijing, China
      Department of radiation oncology, Peking University Third Hospit
    Jun 20, 2023

    Cerebellar Superficial Siderosis in Cerebral Amyloid Angiopathy

    Completed
    • Cerebral Amyloid Angiopathy
    • Siderosis
    • None, pure observational study
    • Nîmes, France
      CHU de Nîmes
    Dec 5, 2022

    Malignant Brain Tumors Trial in Berkel en Rodenrijs (procedure, device, other)

    Recruiting
    • Malignant Brain Tumors
    • intra-arterial injection
    • +2 more
    • Berkel en Rodenrijs, Zuid Holland, Netherlands
      Laurens Groenendijk
    Apr 3, 2023

    Hemangioblastoma of CNS, Von Hippel-Lindau Disease Trial in Le Kremlin Bicêtre (Propranolol, follow-up)

    Not yet recruiting
    • Hemangioblastoma of CNS
    • Von Hippel-Lindau Disease
    • Le Kremlin Bicêtre, France
      AP-HP, Bicêtre Hospital
    Jun 14, 2022

    Brain Tumors Trial in San Diego, Atlanta (Poly ICLC)

    Completed
    • Brain Tumors
    • Poly ICLC
    • San Diego, California
    • +1 more
    Apr 20, 2022

    Metastatic Malignant Peripheral Nerve Sheath Tumor, Neurofibromatosis Type 1, Recurrent Malignant Peripheral Nerve Sheath Tumor

    Recruiting
    • Metastatic Malignant Peripheral Nerve Sheath Tumor
    • +2 more
    • Computed Tomography
    • +4 more
    • Rochester, Minnesota
      Mayo Clinic
    Jul 6, 2022

    Functional Imaging of Cerebellar Mutism Syndrome

    Completed
    • Brain Mass
    • MRI with DTI and fMRI
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Oct 12, 2021

    Malignant Tumor of Bone, Perioperative Period Trial (Tik Tok)

    Not yet recruiting
    • Malignant Tumor of Bone
    • Perioperative Period
    • Tik Tok
    • (no location specified)
    Jan 11, 2023

    Cholangiocarcinoma, Hilar, Biliary Stricture, Hilar Cholangiocarcinoma Trial in Hangzhou (Endoscopic nasobiliary duct cutting,

    Recruiting
    • Cholangiocarcinoma, Hilar
    • +6 more
    • Endoscopic nasobiliary duct cutting
    • Bilateral plastic stent
    • Hangzhou, Zhejiang, China
      Hangzhou First People's Hospital
    Oct 24, 2023